September 20, 2019
Newron Pharmaceuticals: Commercialization partner Meiji Seika together with Eisai get approval of Safinamide for Parkinson’s Disease in Japan
Italian biopharmaceutical specialist for nervous diseases solutions, Newron Pharmaceuticals, and it’s partners Meiji Seika Pharma together with Eisai, got approval to produce and sell Equifina tablets in Japan.